BIO89-100-132 The ENLIGHTEN-Cirrhosis Study
The study will assess the efficacy and safety of pegozafermin administered in participants with compensated cirrhosis due to MASH (biopsy-confirmed fibrosis…
- Investigator
- Virginia C Clark
- Protocol ID
- NCT06419374
- Ages
- 18 Years – 75 Years
- Sexes
- All
- Location
- Gainesville
Akero AK-US-001-0105
- Investigator
- Roberto J Firpi-Morell
- Location
- Gainesville
AK-US-001-0105 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis